Kozuma Y, Kojima H, Yuki S, Suzuki H, Nagasawa T
Division of Hematology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
J Thromb Haemost. 2007 Jun;5(6):1274-82. doi: 10.1111/j.1538-7836.2007.02546.x.
One of the important biological activities of thrombopoietin (TPO) is to prevent the apoptosis of megakaryocytes. As the antiapoptotic protein Bcl-xL, which has been proven to be indispensable for erythroid differentiation, is also abundantly expressed in megakaryocytes, it is assumed that Bcl-xL plays an important role in megakaryopoiesis.
We investigated the expression of Bcl-xL during megakaryopoiesis and the underlying regulatory mechanism.
In stem cell-derived megakaryocytes, expression of Bcl-xL increased in the early and mid-stages of the differentiation. Both in vitro in cell culture and in vivo in an animal model, expression of Bcl-xL protein was maintained until the platelet-producing stage. TPO depletion caused significant decrease in Bcl-xL protein level without affecting its mRNA in both megakaryocytes and TPO-dependent megakaryocytic UT-7/TPO cells, suggesting that Bcl-xL protein level in TPO-dependent cells is post-translationally regulated. In agreement with this finding, we recognized the appearance of a 12-kD fragment of Bcl-xL upon TPO depletion. This cleavage of Bcl-xL was inhibited by a caspase-3-specific inhibitor. Furthermore, pretreatment of UT-7/TPO with a phosphatidylinositol 3-kinase (PI3 K) inhibitor resulted in the cleavage of Bcl-xL even in the presence of TPO. We thus hypothesized that PI3 K inhibits the activation of caspase-3 and consequent cleavage of Bcl-xL. To prove this, we prepared UT-7/TPO cells transfected with constitutively active Akt-1. When TPO was depleted, the transfectant was significantly less liable to caspase-3 activation and Bcl-xL cleavage.
Bcl-xL protein is expressed throughout megakaryopoiesis until platelets are produced, and its expression level is at least in part post-translationally regulated through TPO-mediated Akt activation.
血小板生成素(TPO)的重要生物学活性之一是防止巨核细胞凋亡。抗凋亡蛋白Bcl-xL在红系分化中已被证明是不可或缺的,且在巨核细胞中也大量表达,因此推测Bcl-xL在巨核细胞生成中起重要作用。
我们研究了Bcl-xL在巨核细胞生成过程中的表达及其潜在调控机制。
在干细胞来源的巨核细胞中,Bcl-xL的表达在分化的早期和中期增加。无论是在细胞培养的体外环境还是动物模型的体内环境中,Bcl-xL蛋白的表达一直维持到血小板生成阶段。在巨核细胞和TPO依赖的巨核细胞系UT-7/TPO细胞中,TPO缺失导致Bcl-xL蛋白水平显著降低,但不影响其mRNA水平,这表明TPO依赖细胞中Bcl-xL蛋白水平受到翻译后调控。与此发现一致的是,我们发现在TPO缺失时出现了一个12-kD的Bcl-xL片段。Bcl-xL的这种切割被一种caspase-3特异性抑制剂所抑制。此外,用磷脂酰肌醇3-激酶(PI3K)抑制剂预处理UT-7/TPO细胞,即使在有TPO存在的情况下也会导致Bcl-xL的切割。因此我们推测PI3K抑制caspase-3的激活以及随后Bcl-xL的切割。为了证明这一点,我们制备了转染了组成型活性Akt-1的UT-7/TPO细胞。当TPO缺失时,转染细胞对caspase-3激活和Bcl-xL切割的敏感性显著降低。
Bcl-xL蛋白在整个巨核细胞生成过程中直至血小板产生时都有表达,其表达水平至少部分是通过TPO介导的Akt激活进行翻译后调控的。